I was diagnosed with general anxiety disorder when I was very young—I think I may have been in elementary school. Those early ...

If a pharmacogenomic test result can significantly impact on a treatment decision, either to contraindicate usage of a drug or biologic agent or adjust dosing, product labeling should be modified ...

Pharmacogenomic (PGx) testing is a growing area of personalized medicine with demonstrated clinical utility in improving patient outcomes in oncology. PGx testing of pharmacogenes affecting drug ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on ...

Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

In addition, they emphasized that the CPIC (Clinical Pharmacogenetics Implementation Consortium) and FDA (Food and Drug Administration) advocate for the use of PGx testing, specifically testing CYP2D6 ...

PGx test panel design and test utilization that align with payers’ medical necessity definitions are key to pharmacogenomics laboratories’ financial viability and sustainability. Payers currently ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today provided an update on its engagement with UnitedHealthcare (UNH) following the Nov 1, 2024 publication ...

Pharmacogenomic testing, which identifies how genetic differences affect drug responses, is also gaining traction in personalized medicine. Genetic testing is increasingly used to assess the risk ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine ...

If a pharmacogenomic test result can significantly impact on a treatment decision, either to contraindicate usage of a drug or biologic agent or adjust dosing, product labeling should be modified ...